Sort
23,748 grants matching “melanoma”
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,196,407Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
$1,192,518Hubert M Tse · University Of Kansas Medical Center · R01 · FY2023 · DK
Institutional Clinical and Translational Science Award
$1,192,128Bruce Neil Cronstein · New York University School Of Medicine · UL1 · FY2010 · RR
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
$1,191,796Boro Dropulic · Lentigen Corporation · R44 · FY2010 · CA
Tumor Microenvironment in Cancer Progression
$1,190,749Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
$1,190,547Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
$1,190,423Hubert M Tse · University Of Alabama At Birmingham · R01 · FY2020 · DK
Targeting the MET Pathway in Urothelial Carcinoma
$1,189,328Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
NOVEL INTRACELLULAR ONCOGENIC FUNCTIONS OF CTLA4 IN MELANOMA
$1,188,750Temple University-Of The Commonwealth System Of Higher Education · · FY2022 · Department of the Army
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,188,642Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Treg-depleting immunotherapy
$1,188,595Peter David Suzdak · Sonoval Llc · R44 · FY2021 · CA
Molecular Mechanisms of UVA induced apotosis and carcinogenesis
$1,188,058Zigang Dong · University Of Arizona · P01 · FY2007 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,187,646Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Mutational and Functional Analysis of Sporadic Malignant Melanoma
$1,187,324Yardena Samuels · National Human Genome Research Institute · ZIA · FY2012 · HG
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,187,307Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
UNDERSTANDING TRANSITION FROM NEVI TO MELANOMA OCCURRING WITHIN THE SKIN EPIDERMIS
$1,186,500New York University · · FY2021 · Defense Health Agency
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,185,403Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
OVERCOMING IMMUNOTHERAPY RESISTANCE IN ACRAL MELANOMA
$1,183,560University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2025 · Defense Health Agency
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$1,182,595James Balow · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Engineering and Imaging 3D genome structure-function dynamics across time scales
$1,181,522Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · U01 · FY2020 · DK
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,178,938Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,178,938Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
SBIR Phase II: Production and formulation of a safe and natural sunscreen to replace ingredients harmful to human and environmental health
$1,178,239Khaled H Almabruk · Gadusol Laboratories, Inc. · · FY2019 · TIP
GENETIC DETERMINANTS OF TUMORIGENESIS
$1,178,123Texas State University-San Marcos · P01 · FY2000 · CA
TARGETING A NOVEL T-CELL INHIBITORY RECEPTOR AND DEVELOP NOVEL IMMUNOPREVENTION APPROACHES FOR MELANOMA
$1,177,500The Cleveland Clinic Foundation · · FY2022 · Defense Health Agency